Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey

F. Çobanoglu (Ankara, Turkey), D. Dogru Ersöz (Ankara, Turkey), E. Çakir (AAAnkara, Turkey), T. Sismanlar Eyüboglu (AAAnkara, Turkey), S. Pekcan (AAAnkara, Turkey), G. Cinel (AAAnkara, Turkey), E. Yalçin (AAAnkara, Turkey), N. Kiper (AAAnkara, Turkey), V. Sen (AAAnkara, Turkey), H. Selimoglu Sen (AAAnkara, Turkey), Ö. Ercan (AAAnkara, Turkey), Ö. Keskin (AAAnkara, Turkey), S. Eltan (AAAnkara, Turkey), L. Muhammed Al Shadfan (AAAnkara, Turkey), H. Yazan (AAAnkara, Turkey), D. Ufuk Altintas (AAAnkara, Turkey), S. Sasihüseyinoglu (AAAnkara, Turkey), N. Sapan (AAAnkara, Turkey), S. Çekiç (AAAnkara, Turkey), H. Çokugras (AAAnkara, Turkey), A. Ayzit Atabek (AAAnkara, Turkey), T. Ramasli Gürsoy (AAAnkara, Turkey), A. Tana Aslan (AAAnkara, Turkey), A. Bingöl (AAAnkara, Turkey), A. Basaran (AAAnkara, Turkey), A. Özdemir (AAAnkara, Turkey), M. Köse (AAAnkara, Turkey), M. Hangül (AAAnkara, Turkey), N. Emiralioglu (AAAnkara, Turkey), G. Tugcu (AAAnkara, Turkey), H. Yüksel (AAAnkara, Turkey), Ö. Yilmaz (AAAnkara, Turkey), F. Orhan (AAAnkara, Turkey), Z. Gayretli Aydin (AAAnkara, Turkey), E. Topal (AAAnkara, Turkey), Z. Tamay (AAAnkara, Turkey), A. Süleyman (AAAnkara, Turkey), D. Can (AAAnkara, Turkey), C. Bal (AAAnkara, Turkey), G. Çaltepe (AAAnkara, Turkey), U. Özçelik (AAAnkara, Turkey)

Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Session: Treatments, adherence and psychosocial aspects of cystic fibrosis
Session type: Thematic Poster
Number: 4518

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Çobanoglu (Ankara, Turkey), D. Dogru Ersöz (Ankara, Turkey), E. Çakir (AAAnkara, Turkey), T. Sismanlar Eyüboglu (AAAnkara, Turkey), S. Pekcan (AAAnkara, Turkey), G. Cinel (AAAnkara, Turkey), E. Yalçin (AAAnkara, Turkey), N. Kiper (AAAnkara, Turkey), V. Sen (AAAnkara, Turkey), H. Selimoglu Sen (AAAnkara, Turkey), Ö. Ercan (AAAnkara, Turkey), Ö. Keskin (AAAnkara, Turkey), S. Eltan (AAAnkara, Turkey), L. Muhammed Al Shadfan (AAAnkara, Turkey), H. Yazan (AAAnkara, Turkey), D. Ufuk Altintas (AAAnkara, Turkey), S. Sasihüseyinoglu (AAAnkara, Turkey), N. Sapan (AAAnkara, Turkey), S. Çekiç (AAAnkara, Turkey), H. Çokugras (AAAnkara, Turkey), A. Ayzit Atabek (AAAnkara, Turkey), T. Ramasli Gürsoy (AAAnkara, Turkey), A. Tana Aslan (AAAnkara, Turkey), A. Bingöl (AAAnkara, Turkey), A. Basaran (AAAnkara, Turkey), A. Özdemir (AAAnkara, Turkey), M. Köse (AAAnkara, Turkey), M. Hangül (AAAnkara, Turkey), N. Emiralioglu (AAAnkara, Turkey), G. Tugcu (AAAnkara, Turkey), H. Yüksel (AAAnkara, Turkey), Ö. Yilmaz (AAAnkara, Turkey), F. Orhan (AAAnkara, Turkey), Z. Gayretli Aydin (AAAnkara, Turkey), E. Topal (AAAnkara, Turkey), Z. Tamay (AAAnkara, Turkey), A. Süleyman (AAAnkara, Turkey), D. Can (AAAnkara, Turkey), C. Bal (AAAnkara, Turkey), G. Çaltepe (AAAnkara, Turkey), U. Özçelik (AAAnkara, Turkey). Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey. 4518

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Microbiome in Cystic Fibrosis Exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019

A review of Lung Transplantation for Cystic Fibrosis in Ireland in 2017.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Cystic Fibrosis in Iran
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Cardiorespiratory Fitness in an adult Norwegian Cystic Fibrosis Population
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018

The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Non Cystic Fibrosis Bronchiectasis: Results of Bronchiectasis Severity Index and Quality of Life in an Indian population
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020

Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Phenotypic Analysis of a Ferret Model of Cystic Fibrosis
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

The Effects of Nebulizer Cleaning and Disinfection Training On The Knowledge Levels and Practises of the Caregivers of Patients with Cystic Fibrosis
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Epidemiology of Idiopathic Pulmonary Fibrosis in Australia
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks
Source: Guideline 2015
Year: 2015

Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Nasal Nitric Oxide Sampling In 0-5-year-old Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Controls
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021